Cargando…

New Targeted Therapy for Non-Small Cell Lung Cancer

Lung cancer ranks first in cancer mortality in Korea and cancer incidence in Korean men. More than half of Korean lung cancer patients undergo chemotherapy, including adjuvant therapy. Cytotoxic agents, targeted therapy, and immune checkpoint inhibitors are used in chemotherapy according to the biop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Eun Ki, Yong, Seung Hyun, Lee, Eun Hye, Kim, Eun Young, Chang, Yoon Soo, Lee, Sang Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Tuberculosis and Respiratory Diseases 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816494/ https://www.ncbi.nlm.nih.gov/pubmed/36196556 http://dx.doi.org/10.4046/trd.2022.0066

Ejemplares similares

Prediction model for hyperprogressive disease in non‐small cell lung cancer treated with immune checkpoint inhibitors
por: Choi, Yong Jun, et al.
Publicado: (2020)

Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea
por: Lee, Sung Yong, et al.
Publicado: (2021)

Combination of the LARS1 Inhibitor, BC-LI-0186 with a MEK1/2 Inhibitor Enhances the Anti-Tumor Effect in Non–Small Cell Lung Cancer
por: Lee, Sang Hoon, et al.
Publicado: (2023)

Methionyl-tRNA Synthetase is a Useful Diagnostic Marker for Lymph Node Metastasis in Non-Small Cell Lung Cancer
por: Lee, Jung Mo, et al.
Publicado: (2019)

Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer
por: Lee, Jang Ho, et al.
Publicado: (2023)

Safety and efficacy of 10-fraction hypofractionated radiation therapy for non-small cell lung cancer
por: Yoo, Ye Jin, et al.
Publicado: (2021)

RACK1 is a candidate gene associated with the prognosis of patients with early stage non-small cell lung cancer
por: Choi, Yi-Young, et al.
Publicado: (2015)

Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors
por: Kim, Jehun, et al.
Publicado: (2023)

Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea
por: Lim, Eun-A, et al.
Publicado: (2016)

Expression of key regulatory genes in necroptosis and its effect on the prognosis in non-small cell lung cancer
por: Park, Ji Eun, et al.
Publicado: (2020)

Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non–Small Cell Lung Cancer: Updated Analysis of the RESET Study
por: Kim, Taeyun, et al.
Publicado: (2023)

Clinical features and molecular genetics associated with brain metastasis in suspected early-stage non-small cell lung cancer
por: Kim, Kangjoon, et al.
Publicado: (2023)

Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non‐small‐cell lung cancer harboring EGFR mutations: Results from a real‐world study in South Korea
por: Kim, Taeyun, et al.
Publicado: (2021)

Predictors of Recurrence after Curative Resection in Patients with Early-Stage Non-Small Cell Lung Cancer
por: Lee, Sang Hee, et al.
Publicado: (2015)

Postoperative radiation therapy following the incomplete resection of a non-small cell lung cancer
por: Park, Jaehyeon, et al.
Publicado: (2014)

Non Small Cell Carcinoma Metastasis to Meningioma
por: Kim, Kyung Hyun, et al.
Publicado: (2013)

Compared to plasma, bronchial washing fluid shows higher diagnostic yields for detecting EGFR-TKI sensitizing mutations by ddPCR in lung cancer
por: Lee, Sang Hoon, et al.
Publicado: (2020)

Increased number of subclones in lung squamous cell carcinoma elicits overexpression of immune related genes
por: Song, Myung Jin, et al.
Publicado: (2020)

Association between polymorphisms in microRNA target sites and survival in early‐stage non‐small cell lung cancer
por: Yoo, Seung Soo, et al.
Publicado: (2017)

Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
por: Chang, Ji Young, et al.
Publicado: (2017)

Genetic variants of NEUROD1 target genes are associated with clinical outcomes of small‐cell lung cancer patients
por: Lee, Sunwoong, et al.
Publicado: (2023)

RET Fusion Genes in Korean Non-Small Cell Lung Cancer
por: Yoo, Seung Soo, et al.
Publicado: (2013)

Prediction of postoperative pulmonary complications using preoperative controlling nutritional status (CONUT) score in patients with resectable non-small cell lung cancer
por: Lee, Sang Chul, et al.
Publicado: (2020)

Usefulness of Bronchoscopic Rebiopsy of Non-Small Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
por: Goag, Eun Kyong, et al.
Publicado: (2018)

Picropodophyllotoxin Inhibits Cell Growth and Induces Apoptosis in Gefitinib-Resistant Non-Small Lung Cancer Cells by Dual-Targeting EGFR and MET
por: Lee, Jin-Young, et al.
Publicado: (2023)

Tumor clonal status predicts clinical outcomes of lung adenocarcinoma with EGFR-TKI sensitizing mutation
por: Kim, Eun Young, et al.
Publicado: (2019)

Novel Dimer Derivatives of PF-543 as Potential Antitumor Agents for the Treatment of Non-Small Cell Lung Cancer
por: Kim, Su Bin, et al.
Publicado: (2022)

SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer
por: Kwak, Yoo-Kang, et al.
Publicado: (2020)

Traditional herbal medicine combined with first-line platinum-based chemotherapy for advanced non-small-cell lung cancer: A PRISMA-compliant systematic review and meta-analysis
por: Jin, Hayun, et al.
Publicado: (2021)

Subtype-Based Microbial Analysis in Non-small Cell Lung Cancer
por: Jang, Hye Jin, et al.
Publicado: (2023)

Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancer
por: Kim, Eun Young, et al.
Publicado: (2017)

ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer
por: Kim, Eun Young, et al.
Publicado: (2017)

A Panel of Genetic Polymorphism for the Prediction of Prognosis in Patients with Early Stage Non-Small Cell Lung Cancer after Surgical Resection
por: Lee, Shin Yup, et al.
Publicado: (2015)

Early lung carcinogenesis and tumor microenvironment observed by single-cell transcriptome analysis
por: Kim, Eun Young, et al.
Publicado: (2021)

Intrinsic and Extrinsic Transcriptional Profiles That Affect the Clinical Response to PD-1 Inhibitors in Patients with Non–Small Cell Lung Cancer
por: Byeon, Hye Eun, et al.
Publicado: (2022)

Peripheral lymphocyte count as a surrogate marker of immune checkpoint inhibitor therapy outcomes in patients with non-small-cell lung cancer
por: Lee, Ye Jin, et al.
Publicado: (2022)

High polymerase ε expression associated with increased CD8+T cells improves survival in patients with non-small cell lung cancer
por: Min, Kyueng-Whan, et al.
Publicado: (2020)

ABT-737, a BH3 Mimetic, Enhances the Therapeutic Effects of Ionizing Radiation in K-ras Mutant Non-Small Cell Lung Cancer Preclinical Model
por: Lee, Jung Mo, et al.
Publicado: (2022)

Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease
por: Oh, Sang-Min, et al.
Publicado: (2015)

Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease
por: Oh, Sang‐Min, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_shu3h7oge0noa0eodopokib9g1